General Information of Drug (ID:
DR1308) |
Drug Name |
Pizotifen
|
Synonyms |
Pizotifan; Pizotifen; Pizotifen (INN); Pizotifen [INN]; Pizotifene; Pizotifene [INN-French]; Pizotifeno; Pizotifeno [INN-Spanish]; Pizotifenum; Pizotifenum [INN-Latin]; Pizotyline (USAN); Pizotyline [USAN]; Polomigran; Sandomigran; Sandomygran; 0BY8440V3N; 15574-96-6; 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine; BC 105; BC-105; BRN 0753534; C19H21NS; CHEBI:50212; EINECS 239-632-9; Litec; MFCD00864192; FIADGNVRKBPQEU-UHFFFAOYSA-N; PIZOTYLINE; UNII-0BY8440V3N
|
Indication |
Migraine
[ICD11: 8A80]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
295.4 |
Topological Polar Surface Area |
31.5 |
Heavy Atom Count |
21 |
Rotatable Bond Count |
0 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
2 |
Cross-matching ID |
- PubChem CID
- 27400
- PubChem SID
-
5010370
; 7980344
; 8169757
; 10509182
; 14751522
; 24714723
; 25623658
; 26756535
; 34669927
; 47207192
; 47291792
; 47365864
; 47662958
; 48035805
; 48185659
; 48416449
; 49699409
; 50015996
; 57310432
; 75504446
; 85209443
; 85278783
; 85787805
; 85788911
; 89503750
; 92711291
; 103223858
; 104299887
; 117404128
; 118048642
; 124892409
; 124892410
; 125324589
; 125536630
; 126631018
; 126657449
; 126667030
; 127850175
; 131342662
; 131895591
; 134224322
; 134993421
; 135650835
; 135668219
; 137009871
; 142472728
; 144205577
; 162177650
; 162224663
; 163137347
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D06XZR
- Formula
- C19H21NS
- Canonical SMILES
- CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1
- InChI
- 1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3
- InChIKey
- FIADGNVRKBPQEU-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.